Literature DB >> 19596329

Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population.

Ruth Frikke-Schmidt1.   

Abstract

Epidemiological studies consistently demonstrate a strong inverse association between low levels of high-density lipoprotein (HDL) cholesterol and increased risk of ischemic heart disease (IHD). This review focuses on whether both rare and common genetic variation in ABCA1 contributes to plasma levels of HDL cholesterol and to risk of IHD in the general population, and further seeks to understand whether low levels of HDL cholesterol per se are causally related to IHD. Studies of the ABCA1 gene demonstrate a general strategy for detecting functional genetic variants, and show that both common and rare ABCA1 variants contribute to levels of HDL cholesterol and risk of IHD in the general population. The association between ABCA1 variants and risk of IHD appears, however, to be independent of plasma levels of HDL cholesterol. With the recent identification of the largest number of individuals heterozygous for loss-of-function mutations in ABCA1 worldwide, population studies suggests that genetically low HDL cholesterol per se does not predict an increased risk of IHD, and thus questions the causality of isolated low levels of HDL cholesterol for the development of IHD. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596329     DOI: 10.1016/j.atherosclerosis.2009.06.005

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  34 in total

1.  ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment.

Authors:  Hironobu Akao; Eliana Polisecki; Ernst J Schaefer; Stella Trompet; Michele Robertson; Ian Ford; J Wouter Jukema; Anton J M de Craen; Christopher Packard; Brendan M Buckley; Kouji Kajinami
Journal:  Atherosclerosis       Date:  2014-05-08       Impact factor: 5.162

2.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

Review 3.  Genetics of HDL-C: a causal link to atherosclerosis?

Authors:  Julian C van Capelleveen; Andrea E Bochem; M Mahdi Motazacker; G Kees Hovingh; John J P Kastelein
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

4.  A man with low cholesterol and weakness of the lower limbs.

Authors:  Tiziano Lucchi; Sebastiano Calandra; Claudio Rabacchi; Giancarlo Conti; Gianluca Ardolino; Lara Assolari; Beatrice Arosio; Carlo Vergani
Journal:  Intern Emerg Med       Date:  2014-02-27       Impact factor: 3.397

Review 5.  Treating low high-density lipoprotein cholesterol: what is the evidence?

Authors:  Mirella P Hage; Sami T Azar
Journal:  Ther Adv Endocrinol Metab       Date:  2014-02       Impact factor: 3.565

6.  Intracellular cholesterol-binding proteins enhance HDL-mediated cholesterol uptake in cultured primary mouse hepatocytes.

Authors:  Stephen M Storey; Avery L McIntosh; Huan Huang; Kerstin K Landrock; Gregory G Martin; Danilo Landrock; H Ross Payne; Barbara P Atshaves; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-01-12       Impact factor: 4.052

7.  Ablating L-FABP in SCP-2/SCP-x null mice impairs bile acid metabolism and biliary HDL-cholesterol secretion.

Authors:  Gregory G Martin; Barbara P Atshaves; Kerstin K Landrock; Danilo Landrock; Stephen M Storey; Philip N Howles; Ann B Kier; Friedhelm Schroeder
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-02       Impact factor: 4.052

Review 8.  Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.

Authors:  Kiran Musunuru; Sekar Kathiresan
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

9.  Human FABP1 T94A variant enhances cholesterol uptake.

Authors:  Huan Huang; Avery L McIntosh; Kerstin K Landrock; Danilo Landrock; Stephen M Storey; Gregory G Martin; Shipra Gupta; Barbara P Atshaves; Ann B Kier; Friedhelm Schroeder
Journal:  Biochim Biophys Acta       Date:  2015-02-27

Review 10.  Approach to the patient with extremely low HDL-cholesterol.

Authors:  Daniel J Rader; Emil M deGoma
Journal:  J Clin Endocrinol Metab       Date:  2012-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.